☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Trelegy Ellipta
GSK and Innoviva's Trelegy Ellipta (FF/UMEC/VI) Receive the US FDA's Approval for Asthma and COPD
September 11, 2020
GSK's Trelegy Ellipta (Fluticasone Furoate/Umeclidinium/Vilanterol ‘FF/UMEC/VI') Receives Expanded Level Approval from EU for COPD
November 13, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.